Mechanisms and consequences of bacterial resistance to antimicrobial peptides

Drug Resistance Updates

Volumn 26, Issue , 2016, Pages 43-57

  Andersson, D I ^a   Hughes, D ^a   Kubicek Sutherland, J Z ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anti bacterial drugs; Antimicrobial peptides; Bacterial infections; Innate immunity; Resistance; Selection

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CELL WALL; CROSS RESISTANCE; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; BACTERIUM; DRUG DESIGN; DRUG EFFECTS; IMMUNOLOGY; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; HUMANS; IMMUNITY, INNATE;

EID: 84966441152     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2016.04.002     Document Type: Review

References (180)

1. E. Abachin, C. Poyart, E. Pellegrini, E. Milohanic, F. Fiedler, P. Berche, and P. Trieu-Cuot Formation of d-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes Mol. Microbiol. 43 2002 1 14
2. M.D. Adams, G.C. Nickel, S. Bajaksouzian, H. Lavender, A.R. Murthy, M.R. Jacobs, and R.A. Bonomo Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system Antimicrob. Agents Chemother. 53 2009 3628 3634
3. B. Agerberth, H. Gunne, J. Odeberg, P. Kogner, H.G. Boman, and G.H. Gudmundsson FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis Proc. Natl. Acad. Sci. U. S. A. 92 1995 195 199
4. J.L. Anaya-Lopez, J.E. Lopez-Meza, and A. Ochoa-Zarzosa Bacterial resistance to cationic antimicrobial peptides Crit. Rev. Microbiol. 39 2013 180 195
5. D.I. Andersson, and D. Hughes Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8 2010 260 271
6. D.I. Andersson, and D. Hughes Persistence of antibiotic resistance in bacterial populations FEMS Microbiol. Rev. 2011
7. R.H. Baltz Molecular engineering approaches to peptide, polyketide and other antibiotics Nat. Biotechnol. 24 2006 1533 1540
8. N. Bangalore, J. Travis, V.C. Onunka, J. Pohl, and W.M. Shafer Identification of the primary antimicrobial domains in human neutrophil cathepsin G J. Biol. Chem. 265 1990 13584 13588
9. G. Batoni, G. Maisetta, F.L. Brancatisano, S. Esin, and M. Campa Use of antimicrobial peptides against microbial biofilms: advantages and limits Curr. Med. Chem. 18 2011 256 279
10. M.E. Bauer, and W.M. Shafer On the in vivo significance of bacterial resistance to antimicrobial peptides Biochim. Biophys. Acta 1848 2015 3101 3111
11. A.S. Bayer, R. Prasad, J. Chandra, A. Koul, M. Smriti, A. Varma, R.A. Skurray, N. Firth, M.H. Brown, S.P. Koo, and M.R. Yeaman In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity Infect. Immun. 68 2000 3548 3553
12. J.A. Bengoechea, and M. Skurnik Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia Mol. Microbiol. 37 2000 67 80
13. K.W. Bensch, M. Raida, H.J. Magert, P. Schulz-Knappe, and W.G. Forssmann hBD-1: a novel beta-defensin from human plasma FEBS Lett. 368 1995 331 335
14. A.D. Berti, S.L. Baines, B.P. Howden, G. Sakoulas, V. Nizet, R.A. Proctor, and W.E. Rose Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics Antimicrob. Agents Chemother. 59 2015 2799 2806
15. J. Bradshaw Cationic antimicrobial peptides: issues for potential clinical use BioDrugs 17 2003 233 240
16. G. Brandis, F. Pietsch, R. Alemayehu, and D. Hughes Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis J. Antimicrob. Chemother. 70 2015 680 685
17. K.A. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3 2005 238 250
18. S. Brown, J.P. Santa Maria Jr., and S. Walker Wall teichoic acids of gram-positive bacteria Annu. Rev. Microbiol. 67 2013 313 336
19. A.S. Buchau, J. Schauber, T. Hultsch, A. Stuetz, and R.L. Gallo Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes J. Invest. Dermatol. 128 2008 2646 2654
20. M. Cao, and J.D. Helmann The Bacillus subtilis extracytoplasmic-function sigmaX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides J. Bacteriol. 186 2004 1136 1146
21. H.L. Cash, C.V. Whitham, C.L. Behrendt, and L.V. Hooper Symbiotic bacteria direct expression of an intestinal bactericidal lectin Science 313 2006 1126 1130
22. H.R. Chileveru, S.A. Lim, P. Chairatana, A.J. Wommack, I.L. Chiang, and E.M. Nolan Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5 Biochemistry 54 2015 1767 1777
23. N.X. Chin, and H.C. Neu Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria Am. J. Med. 82 1987 58 62
24. E. de Leeuw, C. Li, P. Zeng, C. Li, M. Diepeveen-de Buin, W.Y. Lu, E. Breukink, and W. Lu Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II FEBS Lett. 584 2010 1543 1548
25. V.K. Dhawan, M.R. Yeaman, A.L. Cheung, E. Kim, P.M. Sullam, and A.S. Bayer Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus Infect. Immun. 65 1997 3293 3299
26. L. Diacovich, and J.P. Gorvel Bacterial manipulation of innate immunity to promote infection Nat. Rev. Microbiol. 8 2010 117 128
27. G. Diamond, J.P. Russell, and C.L. Bevins Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells Proc. Natl. Acad. Sci. U. S. A. 93 1996 5156 5160
28. M.A. Duarte-Vazquez, S. Garcia-Padilla, L. Olvera-Ochoa, K.E. Gonzalez-Romero, J. Acosta-Iniguez, R. De la Cruz-Cordero, and J.L. Rosado Effect of protamine in obesity induced by high-fat diets in rats Int. J. Obes. (Lond.) 33 2009 687 692
29. L.A. Duits, B. Ravensbergen, M. Rademaker, P.S. Hiemstra, and P.H. Nibbering Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells Immunology 106 2002 517 525
30. R.M. Epand, C. Walker, R.F. Epand, and N.A. Magarvey Molecular mechanisms of membrane targeting antibiotics Biochim. Biophys. Acta 2015
31. K.D. Erickson, and C.S. Detweiler The Rcs phosphorelay system is specific to enteric pathogens/commensals and activates ydeI, a gene important for persistent Salmonella infection of mice Mol. Microbiol. 62 2006 883 894
32. C.M. Ernst, P. Staubitz, N.N. Mishra, S.J. Yang, G. Hornig, H. Kalbacher, A.S. Bayer, D. Kraus, and A. Peschel The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion PLoS Pathog. 5 2009 e1000660
33. S.M. Eswarappa, K.K. Panguluri, M. Hensel, and D. Chakravortty The yejABEF operon of Salmonella confers resistance to antimicrobial peptides and contributes to its virulence Microbiology 154 2008 666 678
34. M.E. Falagas, and S.K. Kasiakou Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin. Infect. Dis. 40 2005 1333 1341
35. M.E. Falagas, and S.K. Kasiakou Toxicity of polymyxins: a systematic review of the evidence from old and recent studies Crit. Care 10 2006 R27
36. X.M. Fang, Q. Shu, Q.X. Chen, M. Book, H.G. Sahl, A. Hoeft, and F. Stuber Differential expression of alpha- and beta-defensins in human peripheral blood Eur. J. Clin. Invest. 33 2003 82 87
37. P.I. Fields, E.A. Groisman, and F. Heffron A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells Science 243 1989 1059 1062
38. A. Fleming, and V.D. Allison Observations on a bacteriolytic substance ("lysozyme") found in secretions and tissues Br. J. Exp. Pathol. 3 1922 252 260
39. R.L. Gallo, K.J. Kim, M. Bernfield, C.A. Kozak, M. Zanetti, L. Merluzzi, and R. Gennaro Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse J. Biol. Chem. 272 1997 13088 13093
40. T. Ganz, M.E. Selsted, D. Szklarek, S.S. Harwig, K. Daher, D.F. Bainton, and R.I. Lehrer Defensins. Natural peptide antibiotics of human neutrophils J. Clin. Invest. 76 1985 1427 1435
41. J.R. Garcia, F. Jaumann, S. Schulz, A. Krause, J. Rodriguez-Jimenez, U. Forssmann, K. Adermann, E. Kluver, C. Vogelmeier, D. Becker, R. Hedrich, W.G. Forssmann, and R. Bals Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction Cell Tissue Res. 306 2001 257 264
42. J.R. Garcia, A. Krause, S. Schulz, F.J. Rodriguez-Jimenez, E. Kluver, K. Adermann, U. Forssmann, A. Frimpong-Boateng, R. Bals, and W.G. Forssmann Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity FASEB J. 15 2001 1819 1821
43. M. Garcia-Quintanilla, M. Carretero-Ledesma, P. Moreno-Martinez, R. Martin-Pena, J. Pachon, and M.J. McConnell Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii Int. J. Antimicrob. Agents 46 2015 696 702
44. A. Ghosh, R.K. Kar, J. Jana, A. Saha, B. Jana, J. Krishnamoorthy, D. Kumar, S. Ghosh, S. Chatterjee, and A. Bhunia Indolicidin targets duplex DNA: structural and mechanistic insight through a combination of spectroscopy and microscopy ChemMedChem 9 2014 2052 2058
45. C. Ghosh, and J. Haldar Membrane-active small molecules: designs inspired by antimicrobial peptides ChemMedChem 10 2015 1606 1624
46. R. Glaser, K. Becker, C. von Eiff, U. Meyer-Hoffert, and J. Harder Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides J. Invest. Dermatol. 134 2014 2347 2350
47. W.J. Gooderham, S.L. Gellatly, F. Sanschagrin, J.B. McPhee, M. Bains, C. Cosseau, R.C. Levesque, and R.E. Hancock The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa Microbiology 155 2009 699 711
48. A. Gravesen, M. Ramnath, K.B. Rechinger, N. Andersen, L. Jansch, Y. Hechard, J.W. Hastings, and S. Knochel High-level resistance to class IIa bacteriocins is associated with one general mechanism in Listeria monocytogenes Microbiology 148 2002 2361 2369
49. E.A. Groisman, F. Heffron, and F. Solomon Molecular genetic analysis of the Escherichia coli phoP locus J. Bacteriol. 174 1992 486 491
50. E.A. Groisman, C. Parra-Lopez, M. Salcedo, C.J. Lipps, and F. Heffron Resistance to host antimicrobial peptides is necessary for Salmonella virulence Proc. Natl. Acad. Sci. U. S. A. 89 1992 11939 11943
51. G.H. Gudmundsson, B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes Eur. J. Biochem. 238 1996 325 332
52. T. Guina, E.C. Yi, H. Wang, M. Hackett, and S.I. Miller A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides J. Bacteriol. 182 2000 4077 4086
53. E. Gullberg, S. Cao, O.G. Berg, C. Ilback, L. Sandegren, D. Hughes, and D.I. Andersson Selection of resistant bacteria at very low antibiotic concentrations PLoS Pathog. 7 2011 e1002158
54. J.S. Gunn Bacterial modification of LPS and resistance to antimicrobial peptides J. Endotoxin Res. 7 2001 57 62
55. J.S. Gunn, K.B. Lim, J. Krueger, K. Kim, L. Guo, M. Hackett, and S.I. Miller PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance Mol. Microbiol. 27 1998 1171 1182
56. J.S. Gunn, and S.I. Miller PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella Typhimurium antimicrobial peptide resistance J. Bacteriol. 178 1996 6857 6864
57. J.S. Gunn, S.S. Ryan, J.C. Van Velkinburgh, R.K. Ernst, and S.I. Miller Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium Infect. Immun. 68 2000 6139 6146
58. L. Guo, K.B. Lim, C.M. Poduje, M. Daniel, J.S. Gunn, M. Hackett, and S.I. Miller Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides Cell 95 1998 189 198
59. M.G. Habets, and M.A. Brockhurst Therapeutic antimicrobial peptides may compromise natural immunity Biol. Lett. 8 2012 416 418
60. G. Hao, Y.H. Shi, Y.L. Tang, and G.W. Le The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2 J. Microbiol. 51 2013 200 206
61. J. Harder, J. Bartels, E. Christophers, and J.M. Schroder Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic J. Biol. Chem. 276 2001 5707 5713
62. J. Harder, J. Bartels, E. Christophers, and J.M. Schroder A peptide antibiotic from human skin Nature 387 1997 861
63. J.C. Henderson, C.D. Fage, J.R. Cannon, J.S. Brodbelt, A.T. Keatinge-Clay, and M.S. Trent Antimicrobial peptide resistance of Vibrio cholerae results from an LPS modification pathway related to nonribosomal peptide synthetases ACS Chem. Biol. 9 2014 2382 2392
64. K.A. Henzler Wildman, D.K. Lee, and A. Ramamoorthy Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37 Biochemistry 42 2003 6545 6558
65. K.V. Hoang, Y. Wang, and J. Lin Identification of genetic loci that contribute to Campylobacter resistance to fowlicidin-1, a chicken host defense peptide Front. Cell. Infect. Microbiol. 2 2012 32
66. Y. Hu, F. Liu, I.Y. Lin, G.F. Gao, and B. Zhu Dissemination of the mcr-1 colistin resistance gene Lancet Infect. Dis. 16 2016 146 147
67. G.T. Huang, H.B. Zhang, D. Kim, L. Liu, and T. Ganz A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo Hum. Gene Ther. 13 2002 2017 2025
68. D. Hughes Exploiting genomics, genetics and chemistry to combat antibiotic resistance Nat. Rev. Genet. 4 2003 432 441
69. D. Hughes, and D.I. Andersson Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms Nat. Rev. Genet. 16 2015 459 471
70. L. Imamovic, and M.O. Sommer Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development Sci. Transl. Med. 5 2013 204ra132
71. H. Jenssen, P. Hamill, and R.E. Hancock Peptide antimicrobial agents Clin. Microbiol. Rev. 19 2006 491 511
72. C.W. Kaplan, J.H. Sim, K.R. Shah, A. Kolesnikova-Kaplan, W. Shi, and R. Eckert Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide Antimicrob. Agents Chemother. 55 2011 3446 3452
73. T. Koprivnjak, V. Mlakar, L. Swanson, B. Fournier, A. Peschel, and J.P. Weiss Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus J. Bacteriol. 188 2006 3622 3630
74. D. Kraus, S. Herbert, S.A. Kristian, A. Khosravi, V. Nizet, F. Gotz, and A. Peschel The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses BMC Microbiol. 8 2008 85
75. D. Kraus, and A. Peschel Molecular mechanisms of bacterial resistance to antimicrobial peptides Curr. Top. Microbiol. Immunol. 306 2006 231 250
76. S.A. Kristian, V. Datta, C. Weidenmaier, R. Kansal, I. Fedtke, A. Peschel, R.L. Gallo, and V. Nizet d-Alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion J. Bacteriol. 187 2005 6719 6725
77. J.Z. Kubicek-Sutherland, D.M. Heithoff, S.C. Ersoy, W.R. Shimp, J.K. House, J.D. Marth, J.W. Smith, and M.J. Mahan Host-dependent induction of transient antibiotic resistance: a prelude to treatment failure EBioMedicine 2 2015 1169 1178
78. L.I. Kupferwasser, R.A. Skurray, M.H. Brown, N. Firth, M.R. Yeaman, and A.S. Bayer Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus Antimicrob. Agents Chemother. 43 1999 2395 2399
79. Y. Lai, and R.L. Gallo AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense Trends Immunol. 30 2009 131 141
80. H.M. Lamb, and L.R. Wiseman Pexiganan acetate Drugs 56 1998 1047 1052 discussion 1053-1054
81. D. Landman, C. Georgescu, D.A. Martin, and J. Quale Polymyxins revisited Clin. Microbiol. Rev. 21 2008 449 465
82. R.I. Lehrer, and T. Ganz Defensins of vertebrate animals Curr. Opin. Immunol. 14 2002 96 102
83. M. Li, D.J. Cha, Y. Lai, A.E. Villaruz, D.E. Sturdevant, and M. Otto The antimicrobial peptide-sensing system aps of Staphylococcus aureus Mol. Microbiol. 66 2007 1136 1147
84. B.A. Lipsky, K.J. Holroyd, and M. Zasloff Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream Clin. Infect. Dis. 47 2008 1537 1545
85. Y.J. Liu Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity Cell 106 2001 259 262
86. Y.Y. Liu, Y. Wang, T.R. Walsh, L.X. Yi, R. Zhang, J. Spencer, Y. Doi, G. Tian, B. Dong, X. Huang, L.F. Yu, D. Gu, H. Ren, X. Chen, L. Lv, D. He, H. Zhou, Z. Liang, J.H. Liu, and J. Shen Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study Lancet Infect. Dis. 16 2016 161 168
87. E. Llobet, J.M. Tomas, and J.A. Bengoechea Capsule polysaccharide is a bacterial decoy for antimicrobial peptides Microbiology 154 2008 3877 3886
88. H. Lofton, N. Anwar, M. Rhen, and D.I. Andersson Fitness of Salmonella mutants resistant to antimicrobial peptides J. Antimicrob. Chemother. 70 2015 432 440
89. H. Lofton, M. Pranting, E. Thulin, and D.I. Andersson Mechanisms and fitness costs of resistance to antimicrobial peptides LL-37, CNY100HL and wheat germ histones PLoS ONE 8 2013 e68875
90. M. Macvanin, and D. Hughes Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics FEMS Microbiol. Lett. 247 2005 215 220
91. N. Malanovic, R. Leber, M. Schmuck, M. Kriechbaum, R.A. Cordfunke, J.W. Drijfhout, A. de Breij, P.H. Nibbering, D. Kolb, and K. Lohner Phospholipid-driven differences determine the action of the synthetic antimicrobial peptide OP-145 on Gram-positive bacterial and mammalian membrane model systems Biochim. Biophys. Acta 1848 2015 2437 2447
92. J.M. Manniello, H. Heymann, and F.W. Adair Resistance of spheroplasts and whole cells of Pseudomonas cepacia to polymyxin B Antimicrob. Agents Chemother. 14 1978 500 504
93. A.K. Marr, W.J. Gooderham, and R.E. Hancock Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr. Opin. Pharmacol. 6 2006 468 472
94. W.M. Mars, P. Patmasiriwat, T. Maity, V. Huff, M.M. Weil, and G.F. Saunders Inheritance of unequal numbers of the genes encoding the human neutrophil defensins HP-1 and HP-3 J. Biol. Chem. 270 1995 30371 30376
95. S. Matamouros, and S.I. Miller S. Typhimurium strategies to resist killing by cationic antimicrobial peptides Biochim. Biophys. Acta 1848 2015 3021 3025
96. G.I. McLeod, and M.P. Spector Starvation- and stationary-phase-induced resistance to the antimicrobial peptide polymyxin B in Salmonella Typhimurium is RpoS (sigma(S)) independent and occurs through both phoP-dependent and -independent pathways J. Bacteriol. 178 1996 3683 3688
97. J.B. McPhee, S. Lewenza, and R.E. Hancock Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa Mol. Microbiol. 50 2003 205 217
98. M.N. Melo, D. Dugourd, and M.A. Castanho Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides Recent Pat. Antiinfect. Drug Discov. 1 2006 201 207
99. M.N. Melo, R. Ferre, and M.A. Castanho Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations Nat. Rev. Microbiol. 7 2009 245 250
100. A.S. Michalopoulos, S. Tsiodras, K. Rellos, S. Mentzelopoulos, and M.E. Falagas Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic Clin. Microbiol. Infect. 11 2005 115 121
101. S.I. Miller, and J.J. Mekalanos Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages J. Bacteriol. 172 1990 2485 2490
102. J.H. Moffatt, M. Harper, P. Harrison, J.D. Hale, E. Vinogradov, T. Seemann, R. Henry, B. Crane, F. St Michael, A.D. Cox, B. Adler, R.L. Nation, J. Li, and J.D. Boyce Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production Antimicrob. Agents Chemother. 54 2010 4971 4977
103. F. Morgera, N. Antcheva, S. Pacor, L. Quaroni, F. Berti, L. Vaccari, and A. Tossi Structuring and interactions of human beta-defensins 2 and 3 with model membranes J. Pept. Sci. 14 2008 518 523
104. C. Moser, D.J. Weiner, E. Lysenko, R. Bals, J.N. Weiser, and J.M. Wilson beta-Defensin 1 contributes to pulmonary innate immunity in mice Infect. Immun. 70 2002 3068 3072
105. C. Munck, H.K. Gumpert, A.I. Wallin, H.H. Wang, and M.O. Sommer Prediction of resistance development against drug combinations by collateral responses to component drugs Sci. Transl. Med. 6 2014 262 ra156
106. I. Nagaev, J. Bjorkman, D.I. Andersson, and D. Hughes Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus Mol. Microbiol. 40 2001 433 439
107. K.L. Nawrocki, E.K. Crispell, and S.M. McBride Antimicrobial peptide resistance mechanisms of gram-positive bacteria Antibiotics (Basel) 3 2014 461 492
108. F. Neville, M. Cahuzac, O. Konovalov, Y. Ishitsuka, K.Y. Lee, I. Kuzmenko, G.M. Kale, and D. Gidalevitz Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action Biophys. J. 90 2006 1275 1287
109. A.C. Nilsson, H. Janson, H. Wold, A. Fugelli, K. Andersson, C. Hakangard, P. Olsson, and W.M. Olsen LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus Antimicrob. Agents Chemother. 59 2015 145 151
110. F. Niyonsaba, K. Iwabuchi, H. Matsuda, H. Ogawa, and I. Nagaoka Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway Int. Immunol. 14 2002 421 426
111. F. Niyonsaba, K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa, and I. Nagaoka A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis Immunology 106 2002 20 26
112. V. Nizet Antimicrobial peptide resistance mechanisms of human bacterial pathogens Curr. Issues Mol. Biol. 8 2006 11 26
113. V. Nizet, T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R.A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R.L. Gallo Innate antimicrobial peptide protects the skin from invasive bacterial infection Nature 414 2001 454 457
114. A.J. Ouellette, and M.E. Selsted Paneth cell defensins: endogenous peptide components of intestinal host defense FASEB J. 10 1996 1280 1289
115. G.K. Paterson, D.B. Cone, S.E. Peters, and D.J. Maskell The enzyme phosphoglucomutase (Pgm) is required by Salmonella enterica serovar Typhimurium for O-antigen production, resistance to antimicrobial peptides and in vivo fitness Microbiology 155 2009 3403 3410
116. A. Patrzykat, C.L. Friedrich, L. Zhang, V. Mendoza, and R.E. Hancock Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli Antimicrob. Agents Chemother. 46 2002 605 614
117. W. Paulander, S. Maisnier-Patin, and D.I. Andersson Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella Typhimurium Mol. Microbiol. 64 2007 1038 1048
118. G.G. Perron, M. Zasloff, and G. Bell Experimental evolution of resistance to an antimicrobial peptide Proc. Biol. Sci. 273 2006 251 256
119. A. Peschel, R.W. Jack, M. Otto, L.V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W.F. Nieuwenhuizen, G. Jung, A. Tarkowski, K.P. van Kessel, and J.A. van Strijp Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine J. Exp. Med. 193 2001 1067 1076
120. A. Peschel, M. Otto, R.W. Jack, H. Kalbacher, G. Jung, and F. Gotz Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides J. Biol. Chem. 274 1999 8405 8410
121. D.A. Phoenix, F. Harris, M. Mura, and S.R. Dennison The increasing role of phosphatidylethanolamine as a lipid receptor in the action of host defence peptides Prog. Lipid Res. 59 2015 26 37
122. C. Poyart, E. Pellegrini, M. Marceau, M. Baptista, F. Jaubert, M.C. Lamy, and P. Trieu-Cuot Attenuated virulence of Streptococcus agalactiae deficient in d-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells Mol. Microbiol. 49 2003 1615 1625
123. M. Pranting, and D.I. Andersson Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2 J. Antimicrob. Chemother. 65 2010 876 887
124. M. Pranting, A. Negrea, M. Rhen, and D.I. Andersson Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2 Antimicrob. Agents Chemother. 52 2008 2734 2741
125. L. Robbel, and M.A. Marahiel Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery J. Biol. Chem. 285 2010 27501 27508
126. K.L. Roland, C.R. Esther, and J.K. Spitznagel Isolation and characterization of a gene, pmrD, from Salmonella Typhimurium that confers resistance to polymyxin when expressed in multiple copies J. Bacteriol. 176 1994 3589 3597
127. K.L. Roland, L.E. Martin, C.R. Esther, and J.K. Spitznagel Spontaneous pmrA mutants of Salmonella Typhimurium LT2 define a new two-component regulatory system with a possible role in virulence J. Bacteriol. 175 1993 4154 4164
128. N.H. Salzman, D. Ghosh, K.M. Huttner, Y. Paterson, and C.L. Bevins Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin Nature 422 2003 522 526
129. S. Samant, F.F. Hsu, A.A. Neyfakh, and H. Lee The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides J. Bacteriol. 191 2009 1311 1319
130. O. Samuelsen, H.H. Haukland, H. Jenssen, M. Kramer, K. Sandvik, H. Ulvatne, and L.H. Vorland Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus FEBS Lett. 579 2005 3421 3426
131. O. Samuelsen, H.H. Haukland, B.C. Kahl, C. von Eiff, R.A. Proctor, H. Ulvatne, K. Sandvik, and L.H. Vorland Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B J. Antimicrob. Chemother. 56 2005 1126 1129
132. V. Sass, T. Schneider, M. Wilmes, C. Korner, A. Tossi, N. Novikova, O. Shamova, and H.G. Sahl Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci Infect. Immun. 78 2010 2793 2800
133. P. Schmitt, R.D. Rosa, and D. Destoumieux-Garzon An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes Biochim. Biophys. Acta 2015
134. M.E. Selsted, S.S. Harwig, T. Ganz, J.W. Schilling, and R.I. Lehrer Primary structures of three human neutrophil defensins J. Clin. Invest. 76 1985 1436 1439
135. M.E. Selsted, M.J. Novotny, W.L. Morris, Y.Q. Tang, W. Smith, and J.S. Cullor Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils J. Biol. Chem. 267 1992 4292 4295
136. W.M. Shafer, X. Qu, A.J. Waring, and R.I. Lehrer Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family Proc. Natl. Acad. Sci. U. S. A. 95 1998 1829 1833
137. H. Sharma, and R. Nagaraj Human beta-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity PLoS ONE 10 2015 e0119525
138. Y. Shi, M.J. Cromie, F.F. Hsu, J. Turk, and E.A. Groisman PhoP-regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B Mol. Microbiol. 53 2004 229 241
139. Y. Shi, T. Latifi, M.J. Cromie, and E.A. Groisman Transcriptional control of the antimicrobial peptide resistance ugtL gene by the Salmonella PhoP and SlyA regulatory proteins J. Biol. Chem. 279 2004 38618 38625
140. J.A. Silverman, N. Oliver, T. Andrew, and T. Li Resistance studies with daptomycin Antimicrob. Agents Chemother. 45 2001 1799 1802
141. P.K. Singh, H.P. Jia, K. Wiles, J. Hesselberth, L. Liu, B.A. Conway, E.P. Greenberg, E.V. Valore, M.J. Welsh, T. Ganz, B.F. Tack, and P.B. McCray Jr. Production of beta-defensins by human airway epithelia Proc. Natl. Acad. Sci. U. S. A. 95 1998 14961 14966
142. C. Sohlenkamp, and O. Geiger Bacterial membrane lipids: diversity in structures and pathways FEMS Microbiol. Rev. 40 2016 133 159
143. J. Steinmann, S. Halldorsson, B. Agerberth, and G.H. Gudmundsson Phenylbutyrate induces antimicrobial peptide expression Antimicrob. Agents Chemother. 53 2009 5127 5133
144. A.A. Stromstedt, P.E. Kristiansen, S. Gunasekera, N. Grob, L. Skjeldal, and U. Goransson Selective membrane disruption by the cyclotide kalata B7: complex ions and essential functional groups in the phosphatidylethanolamine binding pocket Biochim. Biophys. Acta 2016
145. S. Stumpe, R. Schmid, D.L. Stephens, G. Georgiou, and E.P. Bakker Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli J. Bacteriol. 180 1998 4002 4006
146. C. Subbalakshmi, and N. Sitaram Mechanism of antimicrobial action of indolicidin FEMS Microbiol. Lett. 160 1998 91 96
147. H. Sugiarto, and P.L. Yu Mechanisms of action of ostrich beta-defensins against Escherichia coli FEMS Microbiol. Lett. 270 2007 195 200
148. S. Sun, A. Negrea, M. Rhen, and D.I. Andersson Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium Antimicrob. Agents Chemother. 53 2009 2298 2305
149. R. Tamayo, S.S. Ryan, A.J. McCoy, and J.S. Gunn Identification and genetic characterization of PmrA-regulated genes and genes involved in polymyxin B resistance in Salmonella enterica serovar typhimurium Infect. Immun. 70 2002 6770 6778
150. V. Teixeira, M.J. Feio, and M. Bastos Role of lipids in the interaction of antimicrobial peptides with membranes Prog. Lipid Res. 51 2012 149 177
151. M.C. Territo, T. Ganz, M.E. Selsted, and R. Lehrer Monocyte-chemotactic activity of defensins from human neutrophils J. Clin. Invest. 84 1989 2017 2020
152. K. Thedieck, T. Hain, W. Mohamed, B.J. Tindall, M. Nimtz, T. Chakraborty, J. Wehland, and L. Jansch The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes Mol. Microbiol. 62 2006 1325 1339
153. E. Thulin, M. Sundqvist, and D.I. Andersson Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli Antimicrob. Agents Chemother. 59 2015 1718 1727
154. J.H. Toney Iseganan (IntraBiotics pharmaceuticals) Curr. Opin. Investig. Drugs 3 2002 225 228
155. E.M. Tytler, G.M. Anantharamaiah, D.E. Walker, V.K. Mishra, M.N. Palgunachari, and J.P. Segrest Molecular basis for prokaryotic specificity of magainin-induced lysis Biochemistry 34 1995 4393 4401
156. Y.L. Tzeng, K.D. Ambrose, S. Zughaier, X. Zhou, Y.K. Miller, W.M. Shafer, and D.S. Stephens Cationic antimicrobial peptide resistance in Neisseria meningitidis J. Bacteriol. 187 2005 5387 5396
157. M. Vaara New approaches in peptide antibiotics Curr. Opin. Pharmacol. 9 2009 571 576
158. K.M. Varney, A.M. Bonvin, M. Pazgier, J. Malin, W. Yu, E. Ateh, T. Oashi, W. Lu, J. Huang, M. Diepeveen-de Buin, J. Bryant, E. Breukink, A.D. Mackerell Jr., and E.P. de Leeuw Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II PLoS Pathog. 9 2013 e1003732
159. W.J. Velden, T.M. van Iersel, N.M. Blijlevens, and J.P. Donnelly Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) BMC Med. 7 2009 44
160. O. Vesga, M.C. Groeschel, M.F. Otten, D.W. Brar, J.M. Vann, and R.A. Proctor Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu J. Infect. Dis. 173 1996 739 742
161. P. Viljanen, and M. Vaara Susceptibility of gram-negative bacteria to polymyxin B nonapeptide Antimicrob. Agents Chemother. 25 1984 701 705
162. C.T. Walsh, R.V. O'Brien, and C. Khosla Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds Angew. Chem. Int. Ed. Engl. 52 2013 7098 7124
163. J. Walter, D.M. Loach, M. Alqumber, C. Rockel, C. Hermann, M. Pfitzenmaier, and G.W. Tannock d-Alanyl ester depletion of teichoic acids in Lactobacillus reuteri 100-23 results in impaired colonization of the mouse gastrointestinal tract Environ. Microbiol. 9 2007 1750 1760
164. G. Wang Human antimicrobial peptides and proteins Pharmaceuticals (Basel) 7 2014 545 594
165. G. Wang Improved methods for classification, prediction, and design of antimicrobial peptides Methods Mol. Biol. 1268 2015 43 66
166. G. Wang Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles J. Biol. Chem. 283 2008 32637 32643
167. G. Wang, X. Li, and Z. Wang APD3: the antimicrobial peptide database as a tool for research and education Nucleic Acids Res. 44 2016 D1087 D1093
168. T.T. Wang, F.P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J.W. Hanrahan, S. Mader, and J.H. White Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression J. Immunol. 173 2004 2909 2912
169. G. Weber, J.D. Heilborn, C.I. Chamorro Jimenez, A. Hammarsjo, H. Torma, and M. Stahle Vitamin D induces the antimicrobial protein hCAP18 in human skin J. Invest. Dermatol. 124 2005 1080 1082
170. C.L. Wilson, A.J. Ouellette, D.P. Satchell, T. Ayabe, Y.S. Lopez-Boado, J.L. Stratman, S.J. Hultgren, L.M. Matrisian, and W.C. Parks Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense Science 286 1999 113 117
171. D. Yang, A. Biragyn, D.M. Hoover, J. Lubkowski, and J.J. Oppenheim Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense Annu. Rev. Immunol. 22 2004 181 215
172. D. Yang, Q. Chen, A.P. Schmidt, G.M. Anderson, J.M. Wang, J. Wooters, J.J. Oppenheim, and O. Chertov LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J. Exp. Med. 192 2000 1069 1074
173. S.J. Yang, A.S. Bayer, N.N. Mishra, M. Meehl, N. Ledala, M.R. Yeaman, Y.Q. Xiong, and A.L. Cheung The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides Infect. Immun. 80 2012 74 81
174. M.R. Yeaman, A.S. Bayer, S.P. Koo, W. Foss, and P.M. Sullam Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action J. Clin. Invest. 101 1998 178 187
175. M.R. Yeaman, and N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55 2003 27 55
176. G. Yim, M.N. Thaker, K. Koteva, and G. Wright Glycopeptide antibiotic biosynthesis J. Antibiot. 67 2014 31 41
177. M. Zaiou, V. Nizet, and R.L. Gallo Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence J. Invest. Dermatol. 120 2003 810 816
178. M. Zanetti, R. Gennaro, and D. Romeo Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain FEBS Lett. 374 1995 1 5
179. A.P. Zavascki, L.Z. Goldani, J. Li, and R.L. Nation Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review J. Antimicrob. Chemother. 60 2007 1206 1215
180. H.I. Zeya, and J.K. Spitznagel Antibacterial and enzymic basic proteins from leukocyte lysosomes: separation and identification Science 142 1963 1085 1087